Parameters | N | Mean ± SE | Median (range) |
---|---|---|---|
Age (years) | |||
Male | 22 (53.7%) | 34.68 ± 1.58 | 36 (23–50) |
Female | 19 (46.3%) | 31.58 ± 1.29 | 35 (26–43) |
CLZ time (months) | |||
Male | 10.05 ± 1.74 | 10 (1–32) | |
Female | 6.63 ± 1.15 | 6 (1–24) | |
CLZ dose (mg/day) | |||
Male | 222.73 ± 42.95 | 150 (100–900) | |
Female | 105.26 ± 8.46 | 100 (50–200) | |
CLZ levels (ng/mL) | |||
Male | 290.11 ± 51.56 | 203.25 (44–846) | |
Female | 336.36 ± 29.16 | 321.77 (91–572) | |
DMC levels (ng/mL) | |||
Male | 134.98 ± 12.78 | 108.93 (28–308) | |
Female | 127.17 ± 16.91 | 133.78 (47–245) | |
Number of subjects (percentage) | |||
Tobacco smokers | 12.2% (n = 5) | ||
Marijuana smokers | 4.9% (n = 2) | ||
Drink alcohol (alcoholism) | 7.3% (n = 3) | ||
Drink coffee | 14.6% (n = 6) |